Knowledge on Differences in Screening-attendance Across Population Groups Can Aid in Improving Equal Participation

Improving Equal Participation

Knowledge on Differences in Screening-attendance Across Population Groups Can Aid in Improving Equal Participation Cancer Screening Limitations Addressing Barriers As part of the EUCanScreen Joint Action, Finland participates in a case study that aims to identify individual barriers and facilitators for attendance to the breast cancer screening programme. The Finnish Cancer Registry 💡The novelty and […]

What if Improving Cancer Screening in Europe was not Limited by Science – but by Data Access?

What if Improving Cancer Screening in Europe was not limited by Science – but by Data Access (Ανάρτηση Facebook)

What if Improving Cancer Screening in Europe was not Limited by Science – but by Data Access? Cancer Screening Limitations Addressing Barriers With modern computation enabling more risk-based and personalised screening pathways, the need for data keeps increasing. Yet, cancer screening data in Europe is fragmented, in silos and has different vocabularies and standards. A […]

EUCanScreen Consortium Meeting Successfully Held in Bled

EUCanScreen Consortium Meeting Successfully Held in Bled

EUCanScreen Consortium Meeting Successfully Held in Bled 11-12 March 2026 In Person in Bled, Slovenia | Online Agenda Cancer Screening Implementation The EUCanScreen project successfully convened its consortium meeting on 11-12 March 2026, bringing together partners and stakeholders both in person in Bled, Slovenia, and online. The two-day event provided a vital forum for reviewing […]

EUCanScreen Consortium Meeting 2026

EUCanScreen Consortium Event 2026 in Slovenia

EUCanScreen Consortium Meeting 2026 11-12 March 2026 In Person in Bled, Slovenia | Online Agenda The EUCanScreen Consortium Event 2026 will take place on 11–12 March in Bled, Slovenia, bringing together partners from across Europe working to strengthen cancer screening programmes and improve public health outcomes. Organised within the framework of the European Joint Action […]

Moldova Marks World Cancer Day 2026

Moldova Marks World Cancer Day 2026

Moldova Marks World Cancer Day 2026 National TV Outreach and Survivor Engagement World Cancer Day On the occasion of World Cancer Day (4 February 2026), the EUCanScreen partner in the Republic of Moldova — IMSP Institutul Oncologic (IMSPIO) — carried out public awareness and dissemination activities focused on cancer prevention and early detection. IMSPIO Dr. […]

Avoidable Cancer Deaths: a Population-Based Study

cancer screening for people with intellectual disabilities (Ανάρτηση Instagram (45)) (3)

Avoidable Deaths Through the Primary Prevention, Early Detection, and Curative Treatment of Cancer Worldwide A Population-Based Study Available Public Health and Clinical Interventions The International Agency for Research on Cancer (IARC) has published new research estimating the global number of cancer deaths that could potentially be avoided through effective prevention measures, earlier diagnosis, and access […]

IARC at the European Cancer Screening and Early Detection Policy Summit in Brussels

cancer screening for people with intellectual disabilities (Ανάρτηση Instagram (45)) (2)

IARC at the European Cancer Screening and Early Detection Policy Summit in Brussels European Policymakers and Researchers Discuss Expanding Evidence-based Cancer Screening Programmes European Cancer Screening and Early Detection Policy Summit Scientists from the International Agency for Research (IARC) on Cancer participated in the European Cancer Screening and Early Detection Policy Summit. It held on […]

Finns are also among the most screening friendly people!

Finns are also among the most screening friendly people!

Finns are also among the most screening friendly people! Finland is not only the happiest country in the world. Finland Cancer Screening Programmes Finland is not only the happiest country in the world. Finns are also among the most screening‑friendly people! Participation rates in national cancer screening programmes are exceptionally high and reflect strong public […]